CliniSys launches laboratory information management system for genomic laboratories
CliniSys | MIPS has launched a new laboratory information management system for genomic laboratories in the UK. The company has brought GLIMS Genomics to the UK from Europe, where it is being successfully deployed at Poitiers University Hospital in France and will be introduced into seven additional laboratories in coming months.
GLIMS Genomics has been designed to support the effective management of genomic laboratories and the UK launch is particularly timely as the NHS is now delivering a national Genomic Medicine Service for England through seven Genomic Laboratory Hubs.
These aim to deliver a comprehensive,
Emma Huntridge, Business Development Director at CliniSys | MIPS, said: “Genomic medicine is no longer the preserve of a few, small, research groups. It is on the cusp of being an established diagnostic tool for some cohorts of patients.
“To support this development, genomic laboratories need to change; and the technology they use will need to change with them.
“They need to move away from the
“At CliniSys | MIPS, we believe now is the time for them to benefit from all the advantages that a bespoke modern LIMS can provide, and GLIMS Genomics will enable them to do that through its fully
CliniSys Group is an international
GLIMS Genomics was developed by a dedicated team within MIPS and successfully introduced to the European market last year.
Poitiers University Hospital in south west France is in the late stages of deploying the new system to replace “the puzzle” of paper and legacy IT systems that it used to use to handle genetic tests with a
GLIMS Genomics covers the whole genomic testing spectrum and can easily be adapted to handle new techniques. It delivers: a high degree of automation; an easily
This means it offers an effective management,
Emma Huntridge added: “What is known as precision medicine is sending ripples of excitement through the clinical community and holds out enormous potential for patients. However, it depends on the effective management and reporting of tests, and their integration into the patient history.
“That is what GLIMS Genomics is built to do, and with its launch in the UK we very much look forward to supporting genomics laboratories as they prepare for this exciting future.”